Showing results (61-70 of 173) with videos related to

Sort By:
Pageof 18
Hemasphere|January 22, 2025
Secondary lesions and sensitivity to signaling inhibitors in iAMP21 acute lymphoblastic leukemiaFemke M Hormann, Anna Østergaard, Stijn van den Broek, et al.
Blood|February 23, 2024
Tyrosine kinase inhibitor response of ABL-class acute lymphoblastic leukemia: the role of kinase type and SH3 domainInge van Outersterp, Sarah K Tasian, Caitlin E J Reichert, et al.
Pediatric Blood & Cancer|February 27, 2018
Inflammatory myofibroblastic tumors-A retrospective analysis of the Cooperative Weichteilsarkom StudiengruppeStefanie Kube, Christian Vokuhl, Tobias Dantonello, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 14, 2010
Long-term outcome in children with relapsed acute lymphoblastic leukemia after time-point and site-of-relapse stratification and intensified short-course multidrug chemotherapy: results of trial ALL-REZ BFM 90Gesche Tallen, Richard Ratei, Georg Mann, et al.
Leukemia & Lymphoma|July 4, 2018
Daunorubicin during delayed intensification decreases the incidence of infectious complications - a randomized comparison in trial CoALL 08-09Franziska Schramm, Martin Zimmermann, Norbert Jorch, et al.
European Journal of Pediatrics|September 21, 2023
Solid pseudopapillary neoplasms of the pancreas in childhood and adolescence-an analysis of the German Registry for Rare Pediatric Tumors (STEP)Christian Jentzsch, Jörg Fuchs, Abbas Agaimy, et al.
European Journal of Cancer (Oxford, England : 1990)|December 26, 2021
Hypersensitivity to Pegylated E.coli asparaginase as first-line treatment in contemporary paediatric acute lymphoblastic leukaemia protocols: a meta-analysis of the Ponte di Legno Toxicity working groupLeiah J Brigitha, Marta Fiocco, Rob Pieters, et al.
Clinical Rehabilitation|March 9, 2021
Effects of a structured counselling-based intervention to improve physical activity behaviour of adolescents and young adult cancer survivors - the randomized phase II Motivate AYA - MAYA trialJannike Salchow, Barbara Koch, Julia Mann, et al.
Haematologica|July 21, 2007
Survivin and its prognostic significance in pediatric acute B-cell precursor lymphoblastic leukemiaAnja Troeger, Meinolf Siepermann, Gabriele Escherich, et al.
Blood|June 17, 2008
High expression of CD40 on B-cell precursor acute lymphoblastic leukemia blasts is an independent risk factor associated with improved survival and enhanced capacity to up-regulate the death receptor CD95Anja Troeger, Ludmila Glouchkova, Birgit Ackermann, et al.
Pageof 18